Oct 5 (Reuters) - Quantum Genomics SA ALQGC.PA :
* QUANTUM GENOMICS PUBLISHES ITS 2022 FIRST HALF RESULTS AND
REVIEWS ITS ACTIVITY
* AT END OF JUNE 2022, OPERATING INCOME WAS EUR 2.9 MILLION
COMPARED WITH EUR 2.7 MILLION A YEAR EARLIER
* OPERATING RESULT AMOUNTED TO (EUR 9.6 MILLION), COMPARED
WITH
(EUR 7.2 MILLION) AT END OF JUNE 2021
* END-JUNE AFTER ACCOUNTING FOR RESEARCH TAX CREDIT OF EUR
1.2
MILLION, NET RESULT AT JUNE 30, 2022 WAS (EUR 8.8 MILLION).
* AT END OF JUNE 2022, AVAILABLE CASH THUS REACHED EUR 19.5
MILLION COMPARED TO EUR 13.5 MILLION AT DECEMBER 31, 2021
* END-JUNE FINANCIAL DEBTS WERE EUR 3.0 MILLION.
* FIRIBASTAT DEVELOPMENT PROGRAM, NOW IN PHASE III FOR
DIFFICULT
TO TREAT AND RESISTANT HYPERTENSION, IS ON TRACK
Source text for Eikon: ID:nGNX8zMQWX
Further company coverage: ALQGC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))